• Phare
  • Validé par KD/KO

Anticorps Monoclonal anti-WWTR1/TAZ

WWTR1/TAZ Monoclonal Antibody for WB, IHC, IF-P, ELISA

Hôte / Isotype

Mouse / IgG1

Réactivité testée

Humain, rat, souris

Applications

WB, IHC, IF-P, ELISA

Conjugaison

Non conjugué

Publications(16)

CloneNo.

2A12A10

N° de cat : 66500-1-Ig

Synonymes

TAZ, WWTR1, 2A12A10, Transcriptional coactivator with PDZ-binding motif, WW domain-containing transcription regulator protein 1



Applications testées

Résultats positifs en WBcellules A549, cellules 4T1, cellules HeLa, cellules HepG2, cellules HSC-T6, cellules Jurkat, cellules MCF-7, cellules MDA-MB-231, cellules MDA-MB-453s, cellules NIH/3T3
Résultats positifs en IHCtissu de cancer du foie humain, tissu de cancer du sein humain
il est suggéré de démasquer l'antigène avec un tampon de TE buffer pH 9.0; (*) À défaut, 'le démasquage de l'antigène peut être 'effectué avec un tampon citrate pH 6,0.
Résultats positifs en IF-Ptissu de cancer du foie humain,

Dilution recommandée

ApplicationDilution
Western Blot (WB)WB : 1:5000-1:50000
Immunohistochimie (IHC)IHC : 1:300-1:1200
Immunofluorescence (IF)-PIF-P : 1:200-1:800
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Informations sur le produit

66500-1-Ig cible WWTR1/TAZ dans les applications de WB, IHC, IF-P, ELISA et montre une réactivité avec des échantillons Humain, rat, souris

Réactivité Humain, rat, souris
Réactivité citéerat, Humain, souris
Hôte / Isotype Mouse / IgG1
Clonalité Monoclonal
Type Anticorps
Immunogène WWTR1/TAZ Protéine recombinante Ag13330
Nom complet WW domain containing transcription regulator 1
Masse moléculaire calculée 44 kDa
Poids moléculaire observé 55 kDa
Numéro d’acquisition GenBankBC014052
Symbole du gène WWTR1
Identification du gène (NCBI) 25937
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par protéine G
Tampon de stockage PBS with 0.02% sodium azide and 50% glycerol
Conditions de stockageStocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA.

Informations générales

TAZ, also referred as WWTR1, is a transcriptional co-activator with a PDZ-binding motif that is regulated by its interaction with 14-3-3 protein. TAZ is expressed in many primary tumors, such as breast cancer, thyroid carcinoma, colorectal cancer, and glioma. TAZ has been reported to be one of the nuclear effectors of Hippo-related pathways that regulate organ size control, cancer stem cell (CSC) properties, and epithelial-mesenchymal transition (EMT). TAZ has been defined for its role in the nucleus, where it functions directly as a transcriptional regulator by interacting with several nuclear factors as Runx2/Cbfa1, NHERF-2, TEF-1, TBX5, PAX3, PAX8 and TTF-1.

Protocole

Product Specific Protocols
WB protocol for WWTR1/TAZ antibody 66500-1-IgDownload protocol
IHC protocol for WWTR1/TAZ antibody 66500-1-IgDownload protocol
IF protocol for WWTR1/TAZ antibody 66500-1-IgDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

SpeciesApplicationTitle
humanWB

Cell Death Differ

Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma

Authors - Yu-Fei Cao
humanWB

Nat Commun

LPA signaling acts as a cell-extrinsic mechanism to initiate cilia disassembly and promote neurogenesis.

Authors - Huai-Bin Hu
  • KD Validated
mouseWB,IF

Cell Signal

RhoA/ROCK-TAZ Axis regulates bone formation within calvarial trans-sutural distraction osteogenesis

Authors - Junjie Ye
mouseWB,IHC,IF

Front Pharmacol

TAZ Induces Migration of Microglia and Promotes Neurological Recovery After Spinal Cord Injury.

Authors - Xuyang Hu
humanWB

Am J Transl Res

VASN promotes YAP/TAZ and EMT pathway in thyroid carcinogenesis in vitro.

Authors - Adheesh Bhandari
ratWB,IF

Toxicol Appl Pharmacol

Cysteine and glycine rich protein 2 exacerbates vascular fibrosis in pulmonary hypertension through the nuclear translocation of yes-associated protein and transcriptional coactivator with PDZ-binding motif

Authors - Xinghe Chen
{{ptg:RelatedPrimaryAntibodies}}